For example, NR2C2, which can mediate genomic rearrangements by a telomere-related pathway27, is highly correlated with eRNAs in 20 cancer types, ranging from 26.3% in PRAD to 53.7% in KIRP. This evidence concerns the gene NR2C2 and prostate adenocarcinoma.